Loading clinical trials...

Evaluation of the Effect of Nirsevimab on Hospitalizations Due to RSV Infection in Infants Under One Year of Age. | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT06856967

Evaluation of the Effect of Nirsevimab on Hospitalizations Due to RSV Infection in Infants Under One Year of Age.

This study aims to evaluate the impact of Nirsevimab, a monoclonal antibody used for RSV prophylaxis, on reducing RSV- related hospitalizations. It will be conducted at 8 pediatric departments in Tusc...

Lead sponsor: Meyer Children's Hospital IRCCS•8 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Giuseppe Indolfi

CONTACT

+3905556621 giuseppe.indolfi@meyer.it

Related studies

COMPLETEDPhase 1

A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults

NCT02491463 · Respiratory Synctial Virus Infections

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 10, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment138

Start dateDec 2024

Last updatedMar 10, 2025

Condition

Respiratory Synctial Virus Infections

Locations shown

SOC Pediatria Ospedale San Donato

Arezzo, Arezzo

SOC Pediatria Ospedale Santa Maria Annunziata

Bagno a Ripoli, Firenze

SOC Neonatologia e Terapia Intensiva Neonatale, Ospedale San Giovanni Di Dio

Florence, Firenze

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 10, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions